InsidersTradesSigma
Follow the 株式会社坪田ラボ share price and the full insider trade history of the company, a listed equity based in Japan. Shares are listed on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社坪田ラボ has logged 7 insider filings. Market capitalisation: €6.9bn. The latest transaction was filed on 19 June 2026 (Holding update). Among the most active insiders: Kazuo Tsubota. The full history is openly available.
7
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
31Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,335 of 29,063 companies
30.4
score / 100
Value17
Quality43
FCF yld-7.6%
Earn yld-9.9%
EV/EBITDA·
ROE-65%
Gross mgn66%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 June 2026
Declarations7 total
0.064% mcap100.0% of flowShareXTKSEDINET:S100YF9Z
20.7% of flowShareXTKSEDINET:S100WMMF
20.7% of flowShareXTKSEDINET:S100WM4X
ShareXTKSEDINET:S100WLPE
38.0% of flowShareXTKSEDINET:S100UHS0
22.4% of flowShareXTKSEDINET:S100RPDK
100.0% of flowShareXTKSEDINET:S100Q04R
7 of 7 declarations
Acerca de 株式会社坪田ラボ
Tsubota Lab Co., Ltd. es una empresa japonesa especializada en el sector de la salud y farmacéutico. Cotiza en el mercado XTKS.